Fuse Biotherapeutics

Fuse Biotherapeutics

Edit info

  • Founded: 2021
  • Location: Los Angeles, CA
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Therapy area: Immune modulation in oncology
  • Drug types: IMM
  • Lead product: Undisclosed
  • Funding: $9.5M Seed Nov 2021
  • Investors: Viva BioInnovator, Sherpa Healthcare Partners, Ivy Venture Group, Sirona Capital, GC&H Investments


fusebiotx.com

linkedin.com


About:

Fuse Biotherapeutics is developing immune-modifying therapies to treat cancer. Immune responses consist of multiple steps to ensure that it effectively deals with various situations within the body. FuseBio is creating therapies that potentiate two of the major categories of the immune system: innate and adaptive immunity. In this manner, FuseBio hopes to attain potent responses to danger, such as against cancerous cells, without natural breaks in the system that spare healthy tissue using their technology.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com